Cerebrospinal fluid studies in children with cerebral malaria: An excitotoxic mechanism?

American Journal of Tropical Medicine and Hygiene

Volumn 62, Issue 2, 2000, Pages 284-290

  Dobbie, Michael ^a   Crawley, Jane ^b   Waruiru, Catherine ^c   Marsh, Kevin ^d   Surtees, Robert ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

^d KEMRI Ctr Geogr Med Res Coast   (Kenya)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DIHYDROBIOPTERIN; EXCITOTOXIN; NEOPTERIN; QUINOLINIC ACID; TETRAHYDROBIOPTERIN;

ARTICLE; ASTROCYTE; BRAIN MALARIA; CELL ACTIVATION; CEREBROSPINAL FLUID ANALYSIS; CHILD; DISEASE SEVERITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MICROGLIA; PATHOGENESIS;

PROTOZOA;

EID: 0034015657     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.62.284     Document Type: Article

References (68)

1. Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, Marsh K, Tulloch S, Oldfield FS, Hayes R, 1987. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 81: 478-486.
2. Newton CR, Krishna S, 1998. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 79: 1-53.
3. Turner GD, Morrison H, Jones M, Davis TM, Looareesuwan S, Buley ID, Gatter KC, Newbold CI, Pukritayakamee S, Nagachinta B, White NJ, Berendt AR, 1994. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 145: 1057-1069.
4. Esslinger CW, Picot S, Ambroise Thomas P, 1994. Intra-erythrocytic Plasmodium falciparum induces up-regulation of inter-cellular adhesion molecule-1 on human endothelial cells in vitro. Scand J Immunol 39: 229-232.
5. Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM, 1989. Tumour necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol 77: 361-366.
6. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM, 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204.
7. Mantovani A, Sica A, Colotta F, Dejana E, 1990. The role of cytokines as communication signals between leukocytes and endothelial cells. Prog Clin Biol Res 349: 343-353.
8. Schofield L, Novakovic S, Gerold P, Schwarz RT, McConville MJ, Tachado SD, 1996. Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol 156: 1886-1896.
9. Ghigo D, Todde R, Ginsburg H, Costamagna C, Gautret P, Bussolino F, Ulliers D, Giribaldi G, Deharo E, Gabrielli G, Pescarmona G, Bosia A, 1995. Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthasc (NOS) activity and release an NOS-inducing soluble factor. J Exp Med 182: 677-688.
10. Prada J, Kremsner PG, 1995. Enhanced production of reactive nitrogen intermediates in human and murine malaria. Parasitol Today 11: 409-410.
11. Kremsner PG, Winkler S, Wildling E, Prada J, Bienzle U, Graninger W, Nussler AK, 1996. High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 90: 44-47.
12. Tachado SD, Gerold P, McConville MJ, Baldwin T, Quilici D, Schwarz RT, Schofield L, 1996. Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein lyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J Immunol 156: 1897-1907.
13. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A, 1989. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 71: 441-459.
14. Crawley J, Smith S, Kirkham F, Muthinji P, Waruiru C, Marsh K, 1996. Seizures and status epilepticus in childhood cerebral malaria. Q J Med 89: 591-597.
15. Newton CR, Crawley J, Sowumni A, Waruiru C, Mwangi I, English M, Murphy S, Winstanley PA, Marsh K, Kirkham FJ, 1997. Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child 76: 219-226.
16. Brewster DR, Kwiatkowski D, White NJ, 1990. Neurological sequelae of cerebral malaria in children. Lancet 336: 1039-1043.
17. Bondi FS, 1992. The incidence and outcome of neurological abnormalities in childhood cerebral malaria: a long-term follow-up of 62 survivors. Trans R Soc Trop Med Hyg 86: 17-19.
18. Werner ER, Werner Felmaver G, Fuchs D, Hausen A, Reibnegger G, Wachter H, 1989. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem J 262: 861-866.
19. Sakai N, Kaufman S, Milstien S, 1995. Parallel induction of nitric oxide and tetrahydrobioplerin synthesis by cytokines in rat glial cells. J Neurochem 65: 895-902.
20. Sakai N, Kaufman S, Milstein S, 1993. Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line (RAW 264). Mol Pharmacol 43: 6-10.
21. Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP, 1996. Human microglia convert 1-tryptophan into the neurotoxin quinolinic acid. Biochem J 320: 595-597.
22. Stone TW, 1993. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45: 309-379.
23. Lapin IP, 1982. Convulsant action of intracerebroventricularly administered 1-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships. Neuropharmacology 21: 1227-1233.
24. Schwarez R, Whetsell Jr WO, Mangano RM, 1983. Quinolinic acid: an endogenous melabolite that produces axon-sparing lesions in rat brain. Science 219: 316-318.
25. Kim JP, Choi DW, 1987. Quinolinate neurotoxicity in cortical cell culture. Neuroscience 23: 423-432.
26. Giulian D, Vac a K, Corpuz M, 1993. Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 13: 29-37.
27. Choi DW, 1992. Excitotoxic cell death. J Neurobiol 23: 1261-1276.
28. Nathan C, Xie QW, 1994. Regulation of biosynthesis of nitric-oxide. J Biol Chem 269: 13725-13728.
29. Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, Fagni L, 1992. Nitric oxide-induced blockade of NMDA receptors. Neuron 8: 653-662.
30. Lei SZ, Pan ZH, Aggarwal SK, Chen HS, Hartman J, Sucher NJ, Lipton SA, 1992. Effect of nitric oxide production on the 0 redox modulatory site of the NMDA receptor-channel complex. Neuron 8: 1087-1099.
31. Manzoni O, Bockaert J, 1993. Nitric oxide synthase activity endogenously modulates NMDA receptors. J Neurochem 61: 368-370.
32. Mayer B, Werner ER, 1995. In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Naunyn Schmiedebergs Arch Pharmacol 351: 453-463.
33. Werner ER, Werner Felmayer G, Fuchs D, Hausen A, Reibnegger R, Yim JJ, Wachter H, 1991. Biochemistry and function of pteridine synthesis in human and murine macrophages. Pharmacology 59: 276-279.
34. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, 1989. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 27: 81-141.
35. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Warn P, Peshu N, Pasvol G, Snow R, 1995. Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404.
36. Dobbie MS, Surtees RAH, 1997. Concentrations of quinolinic acid in cerebrospinal fluid measured by gas chromatography and electron-impact ionisation mass spectrometry. Age-related changes in a paediatric reference population. J Chromatogr B 696: 53-58.
37. Surtees R, Hyland K, 1990. Cerebrospinal fluid concentrations of S-adenosylmethionine, methionine, and 5-methyltetrahydrofolale in a reference population: Cerebrospinal fluid S-adenosylmethionine declines with age in humans. Biochem Med Metab Biol 44: 192-199.
38. Hyland K, Surtees RAH, Heales SJ, Bowron A, Howells DW, Smith I, 1943. Cerehrospinal fluid concentrations of pterins and metabolites of serotonin and dopaminc in a pediatric reference population. Pediatr Res 34: 10-14.
39. Clelland JD, Brand MP, Bolanos JP, Surtees RAH, Land JM, Heales SJ, 1996. Age dependent changes in the cerehrospinal fluid concentration of nitrite and nitrate. Ann Clin Biochem 33: 71-72.
40. Heyes MP, 1993. Metabolism and neuropathologic significance of quinolinic acid and kynurenic acid. Biochem Soc Trans 21: 83-89.
41. Heyes MP, Saito K, Milstien S, Schiff SJ, 1995. Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children. J Neurol Sci 133: 112-118.
42. Achim CL, Heyes MP, Wiley CA, 1993. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 91: 2769-2775.
43. Brouwers P, Heyes MP, Moss HA, Wolters PL, Poplack DG, Markey SP, Pizzo PA, 1993. Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type I disease: relationships to clinical status and therapeutic response. J Infect Dis 168: 1380-1386.
44. Gisslen M, Chiodi F, Fuchs D, Norkrans G, Svennerholm B, Wachter H, Hagberg L, 1994. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis 26: 523-533.
45. Chatelet P, Hautecoeur P, Dhondt JL, Forzy G, Gallois P, Hayte JM, Warot P, Dereux JF, 1993. Ptéridines non cojuguées et infections neuro-méningées. Rev Neurol (Paris) 149: 331-335.
46. Ott M, Demisch L, Engelhardt W, Fischer PA, 1993. Interleukin-2, soluble interleukin-2-receplor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis. J Neurol 241: 108-114.
47. Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D, 1993. Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis 168: 1285-1288.
48. Millot F, Dhondt JL, Mazingue F, Mechinaud F, Augel JL, Bauters F, Harousseau JL, 1993. Cerebrospinal fluid neopterin levels in children with central nervous system leukemia. Leuk Lymphoma 9: 351-356.
49. Weiss G, Thuma PE, Biemba G, Maheza G, Werner ER, Gordeuk VR, 1998. Cerehrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria. J Infect Dis 177: 1064-1068.
50. Sanni LA, Thomas SR, Tattam BN, Moore DE, Chaudhri G, Stocker R, Hunt NH, 1998. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol 152: 611-619.
51. Naritsin DB, Saito K, Markey SP, Chen CY, Heyes MP, 1995. Metabolism of L-tryplophan to kynurenate and quinolinate in the central nervous system: effects of 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. J Neurochem 65: 2217-2226.
52. Heyes MP, Sailo K, Major EO, Milstien S, Markey SP, Vickers JH, 1993. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryplophan and 4-chloro-3-hydroxyanthranilate. Brain 116: 1425-1450.
53. Batshaw ML, Robinson MB, Hyland K, Djali S, Heyes MP, 1993. Quinolinic acid in children with congenital hyperammonaemia. Ann Neurol 34: 676-680.
54. Howells DW, Hyland K, 1987. Direct analysis of tetrahydrobiopterin in Cerebrospinal fluid by high-performance liquid chromatography with redox electrochemistry: prevention of autoxidation during storage and analysis. Clin Chim Acta 167: 23-30.
55. Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Munyenga D, Misukonis MA, Arnelle DR, Hollis D, McDonald MI, Granger DL, 1996. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 184: 557-567.
56. Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns RE, 1993. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-argmine. Proc Natl Acatl Sci USA 90: 8103-8107.
57. Rhodes P, Leone AM, Francis PL, Struthers AD, Moncada S, Rhodes PM, 1995. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Rex Commun 209: 590-596.
58. Surtees R, Heales S, 1997. A rostrocaudal gradient of nitrate plus nitrite concentrations in CSF J Neurol Neurosurg Psychiatry 62: 100-101.
59. Saller M, Duffy C, Garthwaite J, Strijbos PJ, 1996. Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J Neurochem 66: 1683-1690.
60. Alberati Giani D, Ricciardi Castagnoli P, Kohler C, Cesura AM, 1996. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells. J Neurochem 66: 996-1004.
61. Peterson PK, Hu S, Anderson WR, Chao CC, 1994. Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J Infect Dis 170: 457-460.
62. Brosnan CF, Battislini L, Raine CS, Dickson DW, Casadevall A, Lee SC, 1994. Reactive nitrogen intermediates in human neuropathology: an overview. Der Neurosci 16: 152-161.
63. Westergaard N, Beart PM, Schoushoe A, 1993. Transport of L-[3H]arginine in cultured neurons: characteristics and inhibition by nitric oxide synthase inhibitors. J Neurochem 61: 364-367.
64. Speciale C, Schwarcz R, 1993. On the production and disposition of quinolinic acid in rat brain and liver slices. J Neurochem 60: 212-218.
65. Foster AC, Collins JF, Schwarcz R, 1983. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds. Neuropharmacology 22: 1331-1342.
66. Jones NM, Loiacono RE, Moller M, Beart PM, 1994. Diverse roles for nitric oxide in synaptic signalling after activation of NMDA release-regulating receptors. Neuropharmacology 33: 1351-1356.
67. Connop BP, Boegman RJ, Jhamandas K, Beninger RJ, 1995. Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis. Brain Res 676: 124-132.
68. Lipton SA, 1993. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci 16: 527-532.